CN114504516A - Freckle-removing whitening cream - Google Patents
Freckle-removing whitening cream Download PDFInfo
- Publication number
- CN114504516A CN114504516A CN202210193848.5A CN202210193848A CN114504516A CN 114504516 A CN114504516 A CN 114504516A CN 202210193848 A CN202210193848 A CN 202210193848A CN 114504516 A CN114504516 A CN 114504516A
- Authority
- CN
- China
- Prior art keywords
- parts
- whitening cream
- polyphenol
- lettuce
- lactuca sativa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 62
- 239000006071 cream Substances 0.000 title claims abstract description 45
- 208000003351 Melanosis Diseases 0.000 title claims abstract description 33
- 235000003228 Lactuca sativa Nutrition 0.000 claims abstract description 59
- 240000008415 Lactuca sativa Species 0.000 claims abstract description 38
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 32
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 32
- 240000005993 Lactuca saligna Species 0.000 claims abstract description 31
- 235000003167 Lactuca indica Nutrition 0.000 claims abstract description 23
- 235000003126 Lactuca saligna Nutrition 0.000 claims abstract description 23
- 239000003974 emollient agent Substances 0.000 claims abstract description 22
- 239000003906 humectant Substances 0.000 claims abstract description 22
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 claims abstract description 22
- 230000000694 effects Effects 0.000 claims abstract description 20
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 20
- 239000003755 preservative agent Substances 0.000 claims abstract description 20
- 230000002335 preservative effect Effects 0.000 claims abstract description 20
- 239000002562 thickening agent Substances 0.000 claims abstract description 20
- 229960000401 tranexamic acid Drugs 0.000 claims abstract description 19
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims abstract description 19
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 17
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 17
- 239000002738 chelating agent Substances 0.000 claims abstract description 15
- 239000000516 sunscreening agent Substances 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims abstract description 11
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims abstract description 11
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 claims abstract description 11
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims abstract description 11
- 229940036350 bisabolol Drugs 0.000 claims abstract description 11
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000003086 colorant Substances 0.000 claims abstract description 10
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 52
- 239000000843 powder Substances 0.000 claims description 26
- 241000208822 Lactuca Species 0.000 claims description 23
- 239000000284 extract Substances 0.000 claims description 20
- 238000000605 extraction Methods 0.000 claims description 20
- 235000006708 antioxidants Nutrition 0.000 claims description 16
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
- 229920006037 cross link polymer Polymers 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 13
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical group NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 10
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 10
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 10
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 10
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 9
- 235000003127 Lactuca serriola Nutrition 0.000 claims description 8
- 239000003513 alkali Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 6
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 6
- 238000001704 evaporation Methods 0.000 claims description 6
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 6
- 235000021283 resveratrol Nutrition 0.000 claims description 6
- 229940016667 resveratrol Drugs 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 5
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 5
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 claims description 5
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 claims description 5
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 claims description 5
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 5
- 239000004322 Butylated hydroxytoluene Substances 0.000 claims description 5
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 5
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 5
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 claims description 5
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical group [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 5
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical group CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 5
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 claims description 5
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 5
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical group OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 229960000458 allantoin Drugs 0.000 claims description 5
- 235000013871 bee wax Nutrition 0.000 claims description 5
- 239000012166 beeswax Substances 0.000 claims description 5
- 229960003237 betaine Drugs 0.000 claims description 5
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 5
- 229940095259 butylated hydroxytoluene Drugs 0.000 claims description 5
- 229940073669 ceteareth 20 Drugs 0.000 claims description 5
- 229960000541 cetyl alcohol Drugs 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 5
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 5
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 claims description 5
- 229940075529 glyceryl stearate Drugs 0.000 claims description 5
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 5
- 229940100554 isononyl isononanoate Drugs 0.000 claims description 5
- 229940031674 laureth-7 Drugs 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 5
- 229960001679 octinoxate Drugs 0.000 claims description 5
- 229940100460 peg-100 stearate Drugs 0.000 claims description 5
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 5
- 229920002401 polyacrylamide Polymers 0.000 claims description 5
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 claims description 5
- 229960003415 propylparaben Drugs 0.000 claims description 5
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims description 5
- 229940001584 sodium metabisulfite Drugs 0.000 claims description 5
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 5
- 229940042585 tocopherol acetate Drugs 0.000 claims description 5
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 4
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 4
- 239000009429 Ginkgo biloba extract Substances 0.000 claims description 4
- 244000170916 Paeonia officinalis Species 0.000 claims description 4
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 4
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 4
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 4
- 230000002421 anti-septic effect Effects 0.000 claims description 3
- 229940068052 ginkgo biloba extract Drugs 0.000 claims description 3
- 235000020686 ginkgo biloba extract Nutrition 0.000 claims description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- FBNAWLJSQORPAX-UHFFFAOYSA-N 4-methyl-3-propan-2-ylphenol Chemical compound CC(C)C1=CC(O)=CC=C1C FBNAWLJSQORPAX-UHFFFAOYSA-N 0.000 claims description 2
- 239000001599 crocus sativus l. flower extract Substances 0.000 claims description 2
- 229940076591 saffron extract Drugs 0.000 claims description 2
- 229940008099 dimethicone Drugs 0.000 claims 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims 1
- 229940035437 1,3-propanediol Drugs 0.000 claims 1
- 240000006766 Cornus mas Species 0.000 claims 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract description 20
- 235000005152 nicotinamide Nutrition 0.000 abstract description 11
- 239000011570 nicotinamide Substances 0.000 abstract description 11
- 229960003966 nicotinamide Drugs 0.000 abstract description 11
- 206010014970 Ephelides Diseases 0.000 abstract description 8
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 45
- 210000003491 skin Anatomy 0.000 description 36
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 34
- 238000002156 mixing Methods 0.000 description 29
- 239000007788 liquid Substances 0.000 description 25
- 239000006185 dispersion Substances 0.000 description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 238000012360 testing method Methods 0.000 description 21
- 235000019441 ethanol Nutrition 0.000 description 18
- 238000010438 heat treatment Methods 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 230000036564 melanin content Effects 0.000 description 12
- 102000003425 Tyrosinase Human genes 0.000 description 10
- 108060008724 Tyrosinase Proteins 0.000 description 10
- -1 polydimethylsiloxane Polymers 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- 239000006228 supernatant Substances 0.000 description 10
- 229960002255 azelaic acid Drugs 0.000 description 9
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 9
- 229960004705 kojic acid Drugs 0.000 description 9
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 238000005303 weighing Methods 0.000 description 8
- 238000001514 detection method Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000007619 statistical method Methods 0.000 description 5
- GVWGRUCKLWVZRY-ATDBAKNUSA-N (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N.COC1=CC(\C=C\C(O)=O)=CC=C1O GVWGRUCKLWVZRY-ATDBAKNUSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 230000001804 emulsifying effect Effects 0.000 description 4
- 239000011261 inert gas Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 241000209020 Cornus Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000000692 Student's t-test Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229960000271 arbutin Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical group CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000012353 t test Methods 0.000 description 3
- 244000124209 Crocus sativus Species 0.000 description 2
- 235000015655 Crocus sativus Nutrition 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 230000002457 bidirectional effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 210000002780 melanosome Anatomy 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical group CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- YFTGOBNOJKXZJC-UHFFFAOYSA-N 5,6-dihydroxyindole-2-carboxylic acid Chemical compound OC1=C(O)C=C2NC(C(=O)O)=CC2=C1 YFTGOBNOJKXZJC-UHFFFAOYSA-N 0.000 description 1
- 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 1
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 125000000647 trehalose group Chemical group 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a freckle-removing whitening cream, which comprises the following components: 50-65 parts of water, 3-6 parts of nicotinamide, 0.1-1 part of tranexamic acid, 0.5-3 parts of lactuca sativa polyphenol, 1-3 parts of 4-butylresorcinol, 0.1-1 part of azelaic acid, 0.1-0.5 part of bisabolol, 8-15 parts of an emollient, 5-8 parts of an emulsifier, 6-10 parts of a humectant, 0.5-2 parts of a thickener, 0.5-1 part of an antioxidant, 0.1-0.5 part of an astringent, 0.1-5 parts of a skin conditioner, 0.01-0.05 part of an essence, 0.1-0.7 part of a preservative, 0.002-0.005 part of a colorant, 0.2-0.45 part of a sun-screening agent, 0.1-0.6 part of a pH regulator and 0.01-0.05 part of a chelating agent. According to the invention, the lactuca indica polyphenol, tranexamic acid and nicotinamide are used as active ingredients for whitening and removing freckles, so that a cream product with good whitening and freckles removing effects is obtained.
Description
Technical Field
The invention relates to the field of cosmetics, in particular to spot-removing whitening cream.
Background
Melanin, also known as Mailanin pigment, is commonly found in animals and plants, and is secreted by melanocytes in the basal layer of the skin, where an amino acid (tyrosine) in melanocytes produces a chemical change when stimulated to produce secreted melanin. For example, when the ultraviolet rays in the sunlight irradiate the skin, the chemical action of the ultraviolet rays can change the tyrosine in the melanin to form tyrosinase which is secreted into the skin to absorb the short-wave ultraviolet rays which can cause inflammation, and then the short-wave ultraviolet rays fall off along with keratodermia by virtue of the metabolism or enter a blood circulation system to be discharged out of the body; however, if the exposure time is too long, the exposure amount is too large, and the melanin cannot be removed from the skin at a proper time, the melanin precipitates in the skin, the uniform precipitation causes the skin to appear black, and the uneven color lump precipitates to form black spots or darken freckles.
With the improvement of the living standard of people at present, more and more women pay attention to the appearance of the women, and for the impurity spots on the face, whitening cream with the spot removing function is used for whitening and removing spots.
Disclosure of Invention
The invention aims to provide the spot-removing whitening cream which has small damage to skin and good whitening and spot-removing effects.
The purpose of the invention is realized by adopting the following technical scheme:
the spot-removing whitening cream comprises the following components in parts by weight:
50-65 parts of water, 3-6 parts of nicotinamide, 0.1-1 part of tranexamic acid, 0.5-3 parts of lactuca sativa polyphenol, 1-3 parts of 4-butylresorcinol, 0.1-1 part of azelaic acid, 0.1-0.5 part of bisabolol, 8-15 parts of an emollient, 5-8 parts of an emulsifier, 6-10 parts of a humectant, 0.5-2 parts of a thickener, 0.5-1 part of an antioxidant, 0.1-0.5 part of an astringent, 0.1-5 parts of a skin conditioner, 0.01-0.05 part of an essence, 0.1-0.7 part of a preservative, 0.002-0.005 part of a colorant, 0.2-0.45 part of a sun-screening agent, 0.1-0.6 part of a pH regulator and 0.01-0.05 part of a chelating agent.
Preferably, the emollient is at least one of isononyl isononanoate, ethylhexyl palmitate, ethylhexyl stearate, polydimethylsiloxane, cyclopentadimethylsiloxane, cyclohexasiloxane, beeswax, polydimethylsiloxane crosspolymer.
Preferably, the emulsifier is at least one of glyceryl stearate, potassium cetyl phosphate, cetyl alcohol, PEG-100 stearate, ceteareth-20, PEG-75 stearate.
Preferably, the humectant is at least one of propylene glycol, betaine, trehalose, butylene glycol, 1, 3-propylene glycol, 1, 2-pentanediol, 1, 2-hexanediol, and ethylhexylglycerin.
Preferably, the thickening agent is at least one of acrylic acid/C10-30 alkanol acrylate cross-linked polymer, acrylate/C10-30 alkanol acrylate cross-linked polymer, polyacrylamide, C13-14 isoparaffin, laureth-7 and xanthan gum.
Preferably, the antioxidant is at least one of tocopherol acetate, sodium metabisulfite and butylated hydroxytoluene.
Preferably, the skin conditioner is at least one of dogwood extract, ginkgo biloba extract, peony root extract, saffron extract and resveratrol.
Preferably, the preservative is at least one of methylparaben, propylparaben, o-cymene-5-ol, CI19140, CI 16255.
Preferably, the astringent is allantoin; the sun-screening agent is ethylhexyl methoxycinnamate; the pH regulator is triethanolamine; the chelating agent is disodium EDTA.
Preferably, the lactuca sativa polyphenol is extracted from the rhizomes of lactuca sativa.
Preferably, the method for extracting the lactuca sativa polyphenol comprises the following steps:
step 1, picking fresh wild lettuce, removing roots and stems of the wild lettuce from leaves of the wild lettuce, cleaning the surfaces of the roots, draining, cutting into blocks to obtain wild lettuce blocks, and performing fresh-keeping treatment for later use;
step 2, placing the lettuce blocks in a vacuum drying oven, and drying to remove water to obtain dried lettuce;
step 3, smashing the lactuca sativa into powder, and treating the powder in a superfine pulverizer to obtain lactuca sativa powder;
step 4, placing the lactuca indica powder in an ethanol solution for extraction treatment to obtain a first extracting solution and first filter residue;
and 6, combining the first extracting solution and the second extracting solution, and evaporating under reduced pressure until the mixture is completely dried to obtain the lactuca sativa polyphenol.
Preferably, the blocks in the step 1 are cut into pieces with volume size of 8-12 mm3。
Preferably, in the step 1, the temperature of the preservation treatment is 0-4 ℃, and the preservation treatment is carried out by wrapping with a preservative film.
Preferably, in the step 2, in the drying and dewatering process, the vacuum degree is set to be-0.08 to-0.1 MPa, the temperature is set to be 65 to 85 ℃, and the drying and dewatering time is 3 to 5 hours.
Preferably, in the step 3, the grain diameter of the lactuca sativa powder is 1-5 μm.
Preferably, in the step 4, the mass fraction of the ethanol solution is 60-80%; the mass ratio of the lettuce powder to the ethanol solution is 1: 20-50.
Preferably, in the step 4, the lactuca sativa powder and the ethanol solution are mixed, stirred at the speed of 200-400 rpm for 0.5-1 h at room temperature, subjected to centrifugal separation, and subjected to repeated extraction of the obtained filter residue for three times, and then the supernatant and the precipitate are respectively collected to obtain the first extracting solution and the first filter residue.
Preferably, in the step 5, the alkali solution is a sodium hydroxide solution or a potassium hydroxide solution with a concentration of 1-3 mol/L, and the acid solution is a hydrochloric acid solution with a concentration of 1-3 mol/L; the mass ratio of the first filter residue to the alkali liquor is 1: 30-50.
Preferably, in the step 5, after the first filter residue is mixed with the alkali liquor, the temperature is raised to 35-50 ℃ under the protection of inert gas, and after heat preservation treatment is performed for 3-6 hours, acid liquor is added dropwise to adjust the pH value to be less than 2.
Preferably, in the step 5, ethyl acetate is used as an extracting agent for extraction, and ethanol is used as a solvent for redissolution; and the mass of the ethanol solvent added in the redissolution is 10-20 times of that of the first filter residue.
Preferably, in the step 6, the temperature of the reduced pressure evaporation is set to be 55-65 ℃.
Preferably, the preparation process of the freckle-removing whitening cream comprises the following steps:
s1, weighing water, an emollient, an emulsifier, a humectant and a thickener according to parts by weight, mixing the materials in a first container, heating to 70-80 ℃, and uniformly mixing and dispersing to obtain a first mixed dispersion liquid;
s2, weighing an antioxidant, an astringent, an essence, a preservative, a coloring agent, a sunscreen agent, a chelating agent and a pH regulator according to parts by weight, mixing into a second container, heating to 70-80 ℃, and uniformly mixing and dispersing to obtain a second mixed dispersion liquid;
s3, mixing the first mixed dispersion liquid and the second mixed dispersion liquid into an emulsifying device, heating to 70-80 ℃, adding the arginine ferulate and tranexamic acid weighed according to parts by weight, and uniformly mixing and dispersing to obtain a third mixed dispersion liquid;
and S4, after the third mixed dispersion liquid is cooled to 45-50 ℃, sequentially adding the lactuca sativa polyphenol, tranexamic acid, 4-butyl resorcinol, azelaic acid, bisabolol and nicotinamide which are weighed according to the weight parts, uniformly mixing and dispersing, and cooling to room temperature to obtain the freckle-removing whitening cream.
The invention has the beneficial effects that:
1. according to the invention, the lactuca indica polyphenol, tranexamic acid and nicotinamide are used as active ingredients for whitening and removing freckles, and 4-butyl resorcinol, azelaic acid and bisabolol are used as auxiliary ingredients, so that a cream product with good whitening and freckles removing effects is obtained.
2. The tetrabutyl resorcinol in the invention not only has important effect of inhibiting tyrosinase activity, but also realizes the net penetration and whitening activity by the coordination and simultaneous action of three mechanisms in the melanogenesis process: prior to melanin synthesis, tyrosinase synthesis and glycosylation is hindered, preventing tyrosinase from being absorbed by melanosomes. In the process of Melanin cooperation, the inhibitor inhibits the activity of enzyme, acts as a competitive inhibitor of tyrosinase and TRP1 enzyme, and reduces the formation of intermediate (DHICA Melanin) in the process of promoting the generation of chromogenic Melanin. After melanin synthesis, increased tyrosinase degradation, increased inhibition of melanosome transfer to the stratum corneum, and a slight exfoliation effect.
3. The invention adds tranexamic acid and nicotinamide simultaneously, has the effects of resisting oxidation and improving skin microcirculation to provide skin vitality and luster, and uses the lactuca indica polyphenol to form a safe and efficient repair anti-allergy component, so that the skin surface layer is repaired mildly, the cell metabolism is promoted, and the 'light' spot lightening is realized from the skin surface layer; thereby keeping the bright and moist healthy skin color of the skin. Therefore, the whitening and freckle removing effects are achieved by accelerating the fading of freckles.
4. Compared with the conventional products added with kojic acid and arbutin, the cream product prepared by the invention has lower irritation and better whitening effect. And in the conventional case, kojic acid and niacinamide cannot be used simultaneously, because the acidic condition of kojic acid causes niacinamide to generate nicotinic acid, which not only reduces the whitening effect but also has stronger stimulation to the skin. The lettuce polyphenol used in the invention does not worry about the situation, and the combined action of the lettuce polyphenol, tranexamic acid and nicotinamide has more obvious whitening effect through tests.
5. In addition, the lactuca indica polyphenol in the cream not only has whitening effect, but also has protection and repair effect on sunburn and scytitis of skin, reduces irritation of skin care products to skin, and enhances resistance of skin to the outside.
6. According to the invention, a series of extraction operations are carried out by using the roots and stems of the plant lactuca sativa, the finally extracted lactuca sativa polyphenol has a certain whitening auxiliary effect, and the whitening effect is better improved after the lactuca sativa polyphenol is mixed with tranexamic acid and nicotinamide for use. The method is characterized in that rhizomes of the lactuca sativa are cut into blocks, dried and ground, and then alcohol extraction is carried out, so that cells of the lactuca sativa subjected to vacuum drying and grinding are damaged more greatly, and the release of phenols in the lactuca sativa is promoted to a certain extent by the breakage of the cells, so that the subsequent extraction process can be more efficient; and then performing a bidirectional extraction method of alcohol extraction and alkali extraction, wherein the alcohol extraction is to dissolve free phenol and flavonoid products, the alkali extraction is to dissolve bound phenol, and the reasonable utilization of the bidirectional extraction method can promote the dissolution and extraction of most phenols in the lactuca sativa so as to obtain more extracts.
Drawings
The invention is further illustrated by means of the attached drawings, but the embodiments in the drawings do not constitute any limitation to the invention, and for a person skilled in the art, other drawings can be obtained on the basis of the following drawings without inventive effort.
FIG. 1 is a histogram of the L value measurements;
fig. 2 is a histogram of the results of the melanin content assay.
Detailed Description
For the purpose of more clearly illustrating the present invention and more clearly understanding the technical features, objects and advantages of the present invention, the technical solutions of the present invention will now be described in detail below, but are not to be construed as limiting the implementable scope of the present invention.
The dogwood extract, the ginkgo leaf extract, the peony root extract, the crocus sativus extract and the resveratrol are all purchased from Zhejiang Huishong pharmaceutical Co.
Tyrosinase is a very important part in the process of melanin formation, so that various additives are added into many current cosmetics to control the activity of tyrosinase, so as to inhibit the generation of melanin, and further achieve the effects of removing freckles and whitening. However, the commonly used whitening extracts in existing cosmetics are kojic acid and arbutin.
Arbutin is extracted from folium Vaccinii Vitis-idaeae, contains hydroquinone and glucose as main ingredients, and has effects of inhibiting tyrosinase activity, but has strong irritation to skin, and can be used without exposure to sunlight, and if it is not used properly, it will not inhibit melanin, and can cause melanin precipitation.
Kojic acid is mainly used for whitening the skin, and many consumers use cosmetic products containing kojic acid to lighten freckles and other dark spots of the skin. Kojic acid can inhibit activity of various tyrosinases, has no essential element for forming melanin, and has effects of whitening and lightening speckles. However, kojic acid belongs to acids, so that the kojic acid has certain sensitization, and can cause side effects when being used on intolerant skin, particularly on sensitive muscles and can not be used by pregnant women.
The invention is further described below with reference to the following examples.
Example 1
The spot-removing whitening cream comprises the following components in parts by weight:
56 parts of water, 4 parts of nicotinamide, 0.5 part of tranexamic acid, 2.1 parts of lactuca sativa polyphenol, 2.4 parts of 4-butylresorcinol, 0.6 part of azelaic acid, 0.3 part of bisabolol, 12 parts of an emollient, 6 parts of an emulsifier, 8 parts of a humectant, 1.2 parts of a thickener, 0.8 part of an antioxidant, 0.3 part of an astringent, 2.4 parts of a skin conditioner, 0.03 part of an essence, 0.4 part of a preservative, 0.003 part of a colorant, 0.32 part of a sunscreen agent, 0.4 part of a pH regulator and 0.03 part of a chelating agent.
The emollient is isononyl isononanoate, the emulsifier is glyceryl stearate, the humectant is propylene glycol, the thickener is acrylic acid/C10-30 alkanol acrylate cross-linked polymer, the antioxidant is tocopherol acetate, the skin conditioner is dogwood extract, the preservative is methylparaben, and the astringent is allantoin; the sun-screening agent is ethylhexyl methoxycinnamate; the pH regulator is triethanolamine; the chelating agent is disodium EDTA.
The Lactuca sativa polyphenol is extracted from the rhizome of Lactuca sativa.
The method for extracting the lettuce polyphenol comprises the following steps:
step 1, picking fresh Lactuca indica, removing roots and stems of the Lactuca indica, cleaning the surfaces of the roots, draining, and cutting into pieces with a volume of 10mm3Obtaining a lettuce block, and wrapping the lettuce block with a preservative film at the temperature of 0-4 ℃ for later use;
step 2, placing the lettuce blocks in a vacuum drying oven, setting the vacuum degree to be-0.1 MPa, setting the temperature to be 75 ℃, and drying and dewatering for 4 hours to obtain dried lettuce;
step 3, smashing the lactuca sativa into powder, and treating the powder in a superfine pulverizer to obtain lactuca sativa powder with the particle size of 1-5 microns;
step 4, placing the lactuca indica linn powder into an ethanol solution with the mass fraction of 70% for extraction treatment, wherein the mass ratio of the lactuca indica linn powder to the ethanol solution is 1:35, stirring at the speed of 300rpm at room temperature for 0.5h, performing centrifugal separation, repeatedly extracting the obtained filter residue for three times, and collecting supernatant and precipitate respectively to obtain a first extracting solution and first filter residue;
and 6, combining the first extracting solution and the second extracting solution, and evaporating at 60 ℃ under reduced pressure until the mixture is completely dried to obtain the lactuca indica polyphenol.
The preparation process of the freckle-removing whitening cream comprises the following steps:
s1, weighing water, an emollient, an emulsifier, a humectant and a thickener according to parts by weight, mixing the materials in a first container, heating to 75 ℃, and uniformly mixing and dispersing to obtain a first mixed dispersion liquid;
s2, weighing an antioxidant, an astringent, an essence, a preservative, a coloring agent, a sun-screening agent, a chelating agent and a pH regulator according to parts by weight, mixing into a second container, heating to 75 ℃, and uniformly mixing and dispersing to obtain a second mixed dispersion liquid;
s3, mixing the first mixed dispersion liquid and the second mixed dispersion liquid into an emulsifying device, heating to 75 ℃, adding the arginine ferulate and tranexamic acid weighed according to parts by weight, and uniformly mixing and dispersing to obtain a third mixed dispersion liquid;
and S4, after the third mixed dispersion liquid is cooled to 45 ℃, sequentially adding the lactuca indica polyphenol, tranexamic acid, 4-butyl resorcinol, azelaic acid, bisabolol and nicotinamide which are weighed according to parts by weight, uniformly mixing and dispersing, and cooling to room temperature to obtain the freckle-removing whitening cream.
Example 2
The spot-removing whitening cream comprises the following components in parts by weight:
50 parts of water, 3 parts of nicotinamide, 0.1 part of tranexamic acid, 0.5 part of lactuca sativa polyphenol, 1 part of 4-butyl resorcinol, 0.1 part of azelaic acid, 0.1 part of bisabolol, 8 parts of emollient, 5 parts of emulsifier, 6 parts of humectant, 0.5 part of thickener, 0.5 part of antioxidant, 0.1 part of astringent, 0.1 part of skin conditioner, 0.01 part of essence, 0.1 part of preservative, 0.002 part of colorant, 0.2 part of sunscreen agent, 0.1 part of pH regulator and 0.01 part of chelating agent.
The emollient is ethylhexyl palmitate, the emulsifier is potassium cetyl phosphate, the humectant is betaine, the thickener is acrylate/C10-30 alkanol acrylate cross-linked polymer, the antioxidant is sodium metabisulfite, the skin conditioner is ginkgo biloba extract, the preservative is propyl hydroxybenzoate, and the astringent is allantoin; the sun-screening agent is ethylhexyl methoxycinnamate; the pH regulator is triethanolamine; the chelating agent is disodium EDTA.
The Lactuca sativa polyphenol is extracted from the rhizome of Lactuca sativa.
The method for extracting the lettuce polyphenol comprises the following steps:
step 1, picking fresh Lactuca indica, removing leaves and roots of the Lactuca indicaCleaning the surface of the root, draining, and cutting into pieces with volume of 8mm3Obtaining a lettuce block, and wrapping the lettuce block with a preservative film at the temperature of 0-4 ℃ for later use;
step 2, placing the lettuce blocks in a vacuum drying oven, setting the vacuum degree to be-0.08 MPa, setting the temperature to be 65 ℃, and drying and dewatering for 3 hours to obtain dried lettuce;
step 3, smashing the lactuca sativa into powder, and treating the powder in a superfine pulverizer to obtain lactuca sativa powder with the particle size of 1-5 microns;
step 4, placing the lactuca indica linn powder into an ethanol solution with the mass fraction of 60% for extraction treatment, wherein the mass ratio of the lactuca indica linn powder to the ethanol solution is 1:20, stirring at the speed of 200rpm at room temperature for 0.5h, performing centrifugal separation, repeatedly extracting the obtained filter residue for three times, and collecting supernatant and precipitate respectively to obtain a first extracting solution and first filter residue;
and 6, combining the first extracting solution and the second extracting solution, and evaporating at 55 ℃ under reduced pressure until the mixture is completely dried to obtain the lactuca indica polyphenol.
The preparation process of the freckle-removing whitening cream comprises the following steps:
s1, weighing water, an emollient, an emulsifier, a humectant and a thickener according to parts by weight, mixing the materials in a first container, heating to 70-80 ℃, and uniformly mixing and dispersing to obtain a first mixed dispersion liquid;
s2, weighing an antioxidant, an astringent, an essence, a preservative, a coloring agent, a sun-screening agent, a chelating agent and a pH regulator according to parts by weight, mixing into a second container, heating to 70 ℃, and uniformly mixing and dispersing to obtain a second mixed dispersion liquid;
s3, mixing the first mixed dispersion liquid and the second mixed dispersion liquid into an emulsifying device, heating to 70 ℃, adding the arginine ferulate and tranexamic acid weighed according to parts by weight, and uniformly mixing and dispersing to obtain a third mixed dispersion liquid;
and S4, after the third mixed dispersion liquid is cooled to 45 ℃, sequentially adding the lactuca indica polyphenol, tranexamic acid, 4-butyl resorcinol, azelaic acid, bisabolol and nicotinamide which are weighed according to parts by weight, uniformly mixing and dispersing, and cooling to room temperature to obtain the freckle-removing whitening cream.
Example 3
The spot-removing whitening cream comprises the following components in parts by weight:
65 parts of water, 6 parts of nicotinamide, 1 part of tranexamic acid, 3 parts of lactuca sativa polyphenol, 3 parts of 4-butylresorcinol, 1 part of azelaic acid, 0.5 part of bisabolol, 15 parts of emollient, 8 parts of emulsifier, 10 parts of humectant, 2 parts of thickener, 1 part of antioxidant, 0.5 part of astringent, 5 parts of skin conditioner, 0.05 part of essence, 0.7 part of preservative, 0.005 part of colorant, 0.45 part of sun-screening agent, 0.6 part of pH regulator and 0.05 part of chelating agent.
The skin conditioner is characterized in that the emollient is ethylhexyl stearate, the emulsifier is cetyl alcohol, the humectant is trehalose, the thickener is polyacrylamide, the antioxidant is butylated hydroxytoluene, the skin conditioner is a peony root extract, the preservative is o-cymene-5-alcohol, and the astringent is allantoin; the sun-screening agent is ethylhexyl methoxycinnamate; the pH regulator is triethanolamine; the chelating agent is disodium EDTA.
The Lactuca sativa polyphenol is extracted from the rhizome of Lactuca sativa.
The method for extracting the lettuce polyphenol comprises the following steps:
step 1, picking fresh Lactuca indica, removing roots and stems of the Lactuca indica, cleaning the surfaces of the roots, draining, and cutting into pieces with a volume of 12mm3Obtaining a lettuce block, and wrapping the lettuce block with a preservative film at the temperature of 0-4 ℃ for later use;
step 2, placing the lettuce blocks in a vacuum drying oven, setting the vacuum degree to be-0.1 MPa, setting the temperature to be 85 ℃, and drying and dewatering for 5 hours to obtain dried lettuce;
step 3, smashing the lactuca sativa into powder, and treating the powder in a superfine pulverizer to obtain lactuca sativa powder with the particle size of 1-5 microns;
step 4, placing the lactuca indica linn powder into an ethanol solution with the mass fraction of 80% for extraction treatment, wherein the mass ratio of the lactuca indica linn powder to the ethanol solution is 1:50, stirring at the speed of 400rpm at room temperature for 1h, performing centrifugal separation, repeatedly extracting the obtained filter residue for three times, and then respectively collecting supernatant and precipitate to obtain a first extracting solution and first filter residue;
and 6, combining the first extracting solution and the second extracting solution, and evaporating at 65 ℃ under reduced pressure until the mixture is completely dried to obtain the lactuca indica polyphenol.
The preparation process of the freckle-removing whitening cream comprises the following steps:
s1, weighing water, an emollient, an emulsifier, a humectant and a thickener according to parts by weight, mixing the materials in a first container, heating to 80 ℃, and uniformly mixing and dispersing to obtain a first mixed dispersion liquid;
s2, weighing an antioxidant, an astringent, an essence, a preservative, a coloring agent, a sun-screening agent, a chelating agent and a pH regulator according to parts by weight, mixing into a second container, heating to 80 ℃, and uniformly mixing and dispersing to obtain a second mixed dispersion liquid;
s3, mixing the first mixed dispersion liquid and the second mixed dispersion liquid into an emulsifying device, heating to 80 ℃, adding the arginine ferulate and tranexamic acid weighed according to parts by weight, and uniformly mixing and dispersing to obtain a third mixed dispersion liquid;
and S4, after the third mixed dispersion liquid is cooled to 50 ℃, sequentially adding the lactuca indica polyphenol, tranexamic acid, 4-butyl resorcinol, azelaic acid, bisabolol and nicotinamide which are weighed according to parts by weight, uniformly mixing and dispersing, and cooling to room temperature to obtain the freckle-removing whitening cream.
Example 4
Compared with the embodiment 1, the freckle-removing whitening cream is characterized in that:
the emollient is polydimethylsiloxane, the emulsifier is PEG-100 stearate, the humectant is butanediol, the thickener is C13-14 isoparaffin, the skin conditioner is crocus sativus extract, and the preservative is CI 19140.
Example 5
Compared with the embodiment 1, the freckle-removing whitening cream is characterized in that:
the emollient is cyclopentadimethylsiloxane, the emulsifier is ceteareth-20, the humectant is 1, 3-propylene glycol, the thickener is laureth-7, the skin conditioner is resveratrol, and the preservative is CI 16255.
Example 6
Compared with the embodiment 1, the freckle-removing whitening cream is characterized in that:
the emollient is cyclohexasiloxane, the emulsifier is PEG-75 stearate, the humectant is 1, 2-pentanediol, and the thickener is xanthan gum.
Example 7
Compared with the embodiment 1, the freckle-removing whitening cream is characterized in that:
the emollient is beeswax, and the humectant is 1, 2-hexanediol.
Example 8
Compared with the embodiment 1, the freckle-removing whitening cream is characterized in that:
the emollient is polydimethylsiloxane cross-linked polymer, and the humectant is ethylhexyl glycerol.
Example 9
Compared with the embodiment 1, the freckle-removing whitening cream is characterized in that:
the emollient is selected from isononyl isononanoate, ethylhexyl palmitate, ethylhexyl stearate, polydimethylsiloxane, cyclopentadimethylsiloxane, cyclohexasiloxane, beeswax, and polydimethylsiloxane cross-linked polymer.
The emulsifier is any two of glyceryl stearate, potassium cetyl phosphate, cetyl alcohol, PEG-100 stearate, ceteareth-20, and PEG-75 stearate.
The humectant is any two of propylene glycol, betaine, trehalose, butanediol, 1, 3-propylene glycol, 1, 2-pentanediol, 1, 2-hexanediol, and ethylhexylglycerin.
The thickener is any two of acrylic acid/C10-30 alkanol acrylate cross-linked polymer, acrylate/C10-30 alkanol acrylate cross-linked polymer, polyacrylamide, C13-14 isoparaffin, laureth-7 and xanthan gum.
The antioxidant is any two of tocopherol acetate, sodium metabisulfite and butylated hydroxytoluene.
The skin conditioner is any two of Corni fructus extract, folium Ginkgo extract, radix Paeoniae extract, stigma croci Sativi extract, and resveratrol.
The antiseptic is any two of methyl hydroxybenzoate, propyl hydroxybenzoate, o-cymene-5-alcohol, CI19140, and CI 16255.
Example 10
Compared with the embodiment 1, the freckle-removing whitening cream is characterized in that:
the emollient is selected from isononyl isononanoate, ethylhexyl palmitate, ethylhexyl stearate, polydimethylsiloxane, cyclopentadimethylsiloxane, cyclohexasiloxane, beeswax, and polydimethylsiloxane cross-linked polymer.
The emulsifier is any three of glyceryl stearate, potassium cetyl phosphate, cetyl alcohol, PEG-100 stearate, ceteareth-20, and PEG-75 stearate.
The humectant is any three of propylene glycol, betaine, trehalose, butanediol, 1, 3-propylene glycol, 1, 2-pentanediol, 1, 2-hexanediol and ethylhexylglycerin.
The thickening agent is any three of acrylic acid/C10-30 alkanol acrylate cross-linked polymer, acrylate/C10-30 alkanol acrylate cross-linked polymer, polyacrylamide, C13-14 isoparaffin, laureth-7 and xanthan gum.
The antioxidant is any three of tocopherol acetate, sodium metabisulfite and butylated hydroxytoluene.
The skin conditioner is any three of Corni fructus extract, folium Ginkgo extract, radix Paeoniae extract, stigma croci Sativi extract, and resveratrol.
The antiseptic is any three of methyl hydroxybenzoate, propyl hydroxybenzoate, o-cymene-5-alcohol, CI19140, and CI 16255.
To illustrate the invention more clearly, the following experiments were carried out in relation to the whitening cream prepared in example 1:
first, test purpose
With 3D melanoderm modelFor a testing tool, the whitening cream sample in example 1 is acted on a 3D melanin skin model in a surface administration mode, and the whitening efficacy of the sample to be tested is evaluated through indexes of three dimensions of apparent chromaticity, apparent brightness (L value) and melanin content of the model after administration.
Second, test materials
2.1 test System
2.2 Primary reagents
M-TA culture solution, PBS, sodium hydroxide, DMSO, absolute ethyl alcohol and diethyl ether.
2.3 Main Equipment
CO2Incubator (Thermo, 150I), super clean bench (Sujing Antai, SW-CJ-1F), UVB lamp tube (Philips), upright microscope (Olympus, BX53), colorimeter (Denmark, DSMII), digital display constant temperature water bath (Changzhou, China, HH-4A), and microplate reader (BioTek, Epoch).
Third, testing method
3.1 test protocol
Table 1 sample whitening efficacy evaluation protocol
3.2 model reception
Preparing 6-well plates according to the whitening efficacy evaluation scheme in table 1, adding 3.7mLM-TA culture solution to each well, transferring the model cultured on the air-liquid surface for the 3 rd Day (TA3), i.e., the Day of model reception (Day0), to the 6-well plates which are marked; 3 models were required for each experimental group and all model-loaded 6-well plates were transferred to a CO2 incubator (37 ℃, 5% CO 2).
3.3 administration and UVB stimulation
From the Day of model acceptance (Day0), the negative control, positive control and sample groups were subjected to UVB irradiation treatment (50 mJ/cm) daily2) The blank control group was not subjected to UVB irradiation, and only the culture solution was changed every day. The positive control group (KA, 500. mu.g/mL) and the sample group were administered twice in a dose of 10. mu.L by surface administration in Day3 and Day5, respectively. After the model was cultured continuously for 7 days (Day7), the sample was collected and assayed.
3.4 apparent chroma
After the model culture was completed, the appearance photograph was taken with a camera. The specific photographing standard operation is as follows:
(1) a camera mode: manual operation; setting photographing parameters: focal length 5.8mm, aperture F/8, aperture F22, shutter speed 1/80s, ISO 1600.
(2) The melanin skin model is placed in the center of the colorimetric card for photographing.
3.5L value test
And detecting the L value of the model after the apparent chromaticity detection is finished. The specific detection operation is as follows: placing the model on a flat and firm frame
On the hard white plane, the horny layer is placed upwards, the detection hole of the color difference meter is vertically aligned with the surface of the model for detection, and each model is
The readings were repeated three times and the average was taken as the L value reading for the individual model. The model after detection was placed in a clean EP tube for melanin content determination.
3.6 Melanin content test
And (5) performing melanin content detection on the model after the L value detection is finished. The detection operation is as follows:
(1) placing the model in 1.5ml LEP tubes, labeling, adding 1ml LPBS buffer solution into each tube, shaking for 3min with a vortex oscillator, centrifuging at 2000r/min for 10min with a low-temperature high-speed centrifuge, and discarding the supernatant;
(2) sequentially adding 200 mu L of distilled water, 500 mu L of absolute ethyl alcohol and 500 mu L of diethyl ether into the EP tube in the step (1), fully and uniformly mixing, standing at room temperature for 20min, centrifuging at 3000r/min for 5min, and removing supernatant;
(3) adding 1mL of 1mol/L NaOH aqueous solution containing 10% DMSO, and heating in a water bath at 80 ℃ for 40 min;
(4) after the end of the incubation period, 200. mu.L of the supernatant was pipetted into corresponding wells of a well-labeled 96-well plate, OD was read at 405nm and two replicates of each model were tested in the 96-well plate.
Fourthly, statistical analysis of results
The results are expressed as Mean ± SD using GraphPadPrism mapping. The comparison between groups was performed by statistical analysis of t-test. All statistical analyses were two-tailed. p <0.05 was considered to have significant differences, and p <0.01 was considered to have very significant differences.
Fifth, test results
5.2L value test results
The model after the end of the apparent chromaticity measurement was subjected to L value measurement, and the results are shown in table 2 and fig. 1 (histogram of L value measurement results).
And (3) grouping the tests:
TABLE 2 summary of model L values
Test grouping | Mean value of | SD | P-value |
BC | 68.33 | 1.33 | / |
NC | 64.88 | 1.05 | 0.024# |
PC | 69.27 | 0.55 | 0.003** |
Whitening and freckle-removing cream | 72.43 | 0.5 | 0.000** |
Remarking: when the statistical analysis is carried out by using a t-test method, compared with a BC group, the significance of an NC group is represented by # and P-value <0.05 is represented by #, and P-value <0.01 is represented by # #; the significance of the sample group and PC group was shown as x, P-value <0.05 and P-value <0.01, respectively, compared to the NC group.
Compared with the BC group, the NC group has a significantly decreased L value, and compared with the NC group, the PC group has a significantly increased L value, which indicates that the test conditions are valid.
Compared with an NC group, the sample whitening and freckle removing cream has a remarkable improvement effect on the L value of a melanin model.
5.3 Melanin content test results
The results of the melanin content test on the model after the end of L value test are shown in table 3 and fig. 2 (histogram of the melanin content test results).
TABLE 3 summary of melanin content measurements
Test set | Mean value (μ g/mL) | SD | P-value |
BC | 30.660 | 1.368 | / |
NC | 34.569 | 0.850 | 0.014# |
PC | 30.458 | 1.364 | 0.011* |
Whitening removerSpot cream | 20.523 | 0.660 | 0.000** |
Remarking: when the statistical analysis is carried out by using a t-test method, compared with a BC group, the significance of an NC group is represented by # and P-value <0.05 is represented by #, and P-value <0.01 is represented by # #; the significance of the sample group and PC group was shown as x, P-value <0.05 and P-value <0.01, respectively, compared to the NC group.
Compared with the BC group, the NC group has obviously increased melanin content, and compared with the NC group, the PC group has obviously decreased melanin content, which shows that the test condition is effective.
Compared with an NC group, the sample whitening and freckle removing cream has a remarkable inhibiting effect on the melanin content of a melanin model.
Finally, it should be noted that the above embodiments are only used for illustrating the technical solutions of the present invention, and not for limiting the protection scope of the present invention, although the present invention is described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions can be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention.
Claims (10)
1. The freckle-removing whitening cream is characterized by comprising the following components in parts by weight:
50-65 parts of water, 3-6 parts of nicotinamide, 0.1-1 part of tranexamic acid, 0.5-3 parts of lactuca sativa polyphenol, 1-3 parts of 4-butylresorcinol, 0.1-1 part of azelaic acid, 0.1-0.5 part of bisabolol, 8-15 parts of an emollient, 5-8 parts of an emulsifier, 6-10 parts of a humectant, 0.5-2 parts of a thickener, 0.5-1 part of an antioxidant, 0.1-0.5 part of an astringent, 0.1-5 parts of a skin conditioner, 0.01-0.05 part of an essence, 0.1-0.7 part of a preservative, 0.002-0.005 part of a colorant, 0.2-0.45 part of a sun-screening agent, 0.1-0.6 part of a pH regulator and 0.01-0.05 part of a chelating agent.
2. The spot-removing whitening cream according to claim 1, wherein the emollient is at least one of isononyl isononanoate, ethylhexyl palmitate, ethylhexyl stearate, dimethicone, cyclopentadimethicone, cyclohexasiloxane, beeswax, and dimethicone crosspolymer.
3. The whitening cream with freckle removing effect of claim 1, wherein the emulsifier is at least one of glyceryl stearate, potassium cetyl phosphate, cetyl alcohol, PEG-100 stearate, ceteareth-20 and PEG-75 stearate.
4. The spot-removing whitening cream according to claim 1, wherein the humectant is at least one of propylene glycol, betaine, trehalose, butylene glycol, 1, 3-propanediol, 1, 2-pentanediol, 1, 2-hexanediol, and ethylhexyl glycerin.
5. The spot-removing whitening cream according to claim 1, wherein the thickener is at least one of acrylic acid/C10-30 alkanol acrylate cross-linked polymer, acrylate/C10-30 alkanol acrylate cross-linked polymer, polyacrylamide, C13-14 isoparaffin, laureth-7, and xanthan gum.
6. The whitening cream with freckle removing type according to claim 1, wherein the antioxidant is at least one of tocopherol acetate, sodium metabisulfite and butylated hydroxytoluene.
7. The spot-removing whitening cream according to claim 1, wherein the skin conditioner is at least one of dogwood extract, ginkgo biloba extract, peony root extract, saffron extract and resveratrol.
8. The whitening cream according to claim 1, wherein the antiseptic is at least one of methyl hydroxybenzoate, propyl hydroxybenzoate, o-cymene-5-ol, CI19140 and CI 16255.
9. The spot-removing whitening cream according to claim 1, wherein the astringent is allantoin; the sun-screening agent is ethylhexyl methoxycinnamate; the pH regulator is triethanolamine; the chelating agent is disodium EDTA.
10. The spot-removing whitening cream according to claim 1, wherein the lactuca sativa polyphenol is extracted by the following method:
step 1, picking fresh wild lettuce, removing roots and stems of the wild lettuce from leaves of the wild lettuce, cleaning the surfaces of the roots, draining, cutting into blocks to obtain wild lettuce blocks, and performing fresh-keeping treatment for later use;
step 2, placing the lettuce blocks in a vacuum drying oven, and drying to remove water to obtain dried lettuce;
step 3, smashing the lactuca sativa into powder, and treating the powder in a superfine pulverizer to obtain lactuca sativa powder;
step 4, placing the lactuca indica powder in an ethanol solution for extraction treatment to obtain a first extracting solution and first filter residue;
step 5, treating the first filter residue in alkali liquor, then dropwise adding acid liquor to adjust the pH value to be less than 2, then centrifuging and collecting supernate, and extracting and redissolving to obtain a second extracting solution;
and 6, combining the first extracting solution and the second extracting solution, and evaporating under reduced pressure until the mixture is completely dried to obtain the lactuca sativa polyphenol.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210193848.5A CN114504516A (en) | 2022-03-01 | 2022-03-01 | Freckle-removing whitening cream |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210193848.5A CN114504516A (en) | 2022-03-01 | 2022-03-01 | Freckle-removing whitening cream |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114504516A true CN114504516A (en) | 2022-05-17 |
Family
ID=81553213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210193848.5A Pending CN114504516A (en) | 2022-03-01 | 2022-03-01 | Freckle-removing whitening cream |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114504516A (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002179516A (en) * | 2000-12-13 | 2002-06-26 | Pola Chem Ind Inc | Skin-whitening composition |
JP2011178751A (en) * | 2010-03-03 | 2011-09-15 | Kao Corp | Whitening agent |
EP3042662A1 (en) * | 2015-01-12 | 2016-07-13 | Biolie | Lettuce extracts, compositions and uses |
KR20170138951A (en) * | 2016-06-08 | 2017-12-18 | 서울대학교산학협력단 | Cosmetic composition, health functional food and probiotics combined preparation comprising extract from lactuca sativa var. capitata |
CN110200874A (en) * | 2019-07-08 | 2019-09-06 | 卢琛 | A kind of whitening and spot eliminating cream and preparation method thereof |
CN110420160A (en) * | 2019-05-27 | 2019-11-08 | 广州好蝶化妆品有限公司 | A kind of whitening and spot eliminating cream and preparation method |
KR20200012532A (en) * | 2018-07-27 | 2020-02-05 | 이은주 | Cosmetic compositions for skin moisturizing comprising bamboo distillates as active ingredients and mask pack comprising the composition |
CN113648257A (en) * | 2021-09-16 | 2021-11-16 | 广州芳利医药科技有限公司 | Whitening and freckle-removing composition and preparation method and application thereof |
-
2022
- 2022-03-01 CN CN202210193848.5A patent/CN114504516A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002179516A (en) * | 2000-12-13 | 2002-06-26 | Pola Chem Ind Inc | Skin-whitening composition |
JP2011178751A (en) * | 2010-03-03 | 2011-09-15 | Kao Corp | Whitening agent |
EP3042662A1 (en) * | 2015-01-12 | 2016-07-13 | Biolie | Lettuce extracts, compositions and uses |
KR20170138951A (en) * | 2016-06-08 | 2017-12-18 | 서울대학교산학협력단 | Cosmetic composition, health functional food and probiotics combined preparation comprising extract from lactuca sativa var. capitata |
KR20200012532A (en) * | 2018-07-27 | 2020-02-05 | 이은주 | Cosmetic compositions for skin moisturizing comprising bamboo distillates as active ingredients and mask pack comprising the composition |
CN110420160A (en) * | 2019-05-27 | 2019-11-08 | 广州好蝶化妆品有限公司 | A kind of whitening and spot eliminating cream and preparation method |
CN110200874A (en) * | 2019-07-08 | 2019-09-06 | 卢琛 | A kind of whitening and spot eliminating cream and preparation method thereof |
CN113648257A (en) * | 2021-09-16 | 2021-11-16 | 广州芳利医药科技有限公司 | Whitening and freckle-removing composition and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103284940B (en) | Saccharomycetes fermented traditional Chinese medicine composition, as well as preparation method and application thereof | |
CN104027293B (en) | A kind of skin-lightening cosmetic and preparation method thereof | |
CN106727147B (en) | Herbal American Ginseng Skin Beauty Improvement Medicine and Cosmetic Application and Preparation | |
JP2021020887A (en) | Enhanced anti-aging cosmetic composition | |
US20180353424A1 (en) | Camellia extract, its preparation method, and its use | |
JP2021020886A (en) | Anti-aging cosmetic composition | |
CN105381007B (en) | Externally applied traditional Chinese medicine composition and preparation with whitening effect, preparation method and application thereof | |
CN111067835A (en) | Whitening composition for resisting skin saccharification reaction and preparation method thereof | |
CN109276529A (en) | A kind of lightening compositions and the whitening lotion comprising the composition | |
CN113750015A (en) | Acne removing composition with acne mark removing and scar removing effects and preparation method thereof | |
CN109925247A (en) | A kind of toner and preparation method thereof with full stage anti-acne effect | |
CN110151619B (en) | Sunscreen composition containing multiple active substances | |
CN108324636A (en) | A kind of skin care compositions and with careful pore effect cosmetic, preparation method | |
CN113041190B (en) | Antioxidant composition, preparation method and application | |
CN106214548B (en) | A kind of Skin whitening care cosmetics composition and preparation method thereof | |
CN115944581A (en) | Rose cell sap as well as preparation method and application thereof | |
CN105596273B (en) | Clear Virgin's milk liquid of a kind of Shu Run and preparation method thereof | |
CN110711165A (en) | Anti-aging firming beauty cream containing kangaroo paw extract | |
CN119015167A (en) | A skin color improving composition and its preparation method and application | |
CN100588389C (en) | Chinese medicine combination with whitening function and uses thereof | |
CN101357114A (en) | Whitening antioxidation cosmetic compositions | |
CN114504516A (en) | Freckle-removing whitening cream | |
CN111184824A (en) | Freckle-removing traditional Chinese medicine liquid and preparation method thereof | |
CN110025551A (en) | A kind of draft anti-wrinkle face mask and preparation method thereof | |
CA2421160A1 (en) | Cosmetic composition containing the extract of mountain ginseng adventitious roots |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220517 |